INTRODUCTION
Intercenter variations in neonatal morbidity and mortality are well described, but the specific factors leading to these differences are not well understood. [1] [2] [3] [4] Preterm newborns delivered in a tertiary care center (inborn) appear to have improved outcomes when compared with preterm newborns transferred to a tertiary center after birth (outborn), thus supporting the regionalization of care and the need to enhance maternal transport programs. [5] [6] [7] However, studies comparing neonatal outcomes between hospitals are limited by variations in patient demographics, prenatal and obstetric care, severity of maternal and neonatal illness severity, the neonatal care available, methods of data collection, and the definition and measurement of specific outcomes.
Few studies have collected data prospectively to compare the outcomes of inborn versus outborn preterm neonates. Most reports are based on retrospective cohort studies, either from one tertiary referral center or from multiple centers using nonuniform outcome assessments. 5, 8, 9 In these studies, moreover, the evaluated outcomes were limited to mortality and/or neurologic disability. A population-based cohort study recently found that the odds of death or major morbidity for outborn very low birth weight babies were twice those of infants born at tertiary centers, but major differences in neonatal care (i.e. continued neonatal hospitalization at referring versus tertiary centers) were not considered in the analysis. 10 Towers et al. 6 reported a higher risk of severe intraventricular hemorrhage (IVH) (Grade III or IV) in a prospective cohort study among infants born at hospitals with Level I neonatal intensive care units (NICUs) and transported to a tertiary referral center (outborn) compared with those delivered at the tertiary referral center (inborn). In Canada, where neonatal care is highly regionalized, a prospective study found lower mortality and IVH rates in babies of r26 weeks gestation and reduced CLD in babies of 27 to 29 weeks gestation among inborn versus outborn neonates.
The Neurologic Outcomes & Preemptive Analgesia In Neonates (NEOPAIN) trial offered a unique opportunity to analyze data collected prospectively within a uniform protocol on premature infants who were enrolled in a randomized, controlled clinical trial at tertiary care NICUs. 12 The NEOPAIN trial protocol included stringent criteria to diagnose specific outcomes, uniform training for all study coordinators, data collection by fax-entry, data management/quality control at a central coordinating center, and centralized assessment of cranial sonograms. 12 
MATERIALS AND METHODS
We utilized features of the NEOPAIN trial database to assess the effect of birth hospital (inborn versus outborn) on the following clinical outcomes of ventilated preterm neonates (23 to 32 weeks gestation): severe intraventricular hemorrhage (Grade III or IV) and periventricular leukomalacia, chronic lung disease, and mortality.
The NEOPAIN trial was designed as a randomized, placebocontrolled study to evaluate the effects of pre-emptive morphine analgesia on mortality, severe IVH, and PVL. The trial enrolled 898 preterm neonates from 12 tertiary NICUs (Level III or higher) in the United States and four in Europe. 12 The strengths of this study included a large sample size, standardized approaches for therapeutic management and data collection, centralized assessment of cranial sonography, and complete follow-up for most patients. The generalizability of NEOPAIN data was aided by limited exclusion criteria, enrollment from American and European centers, university-affiliated and community hospitals, and large and small NICUs. Clinical bias was minimized by maintaining a log of all eligible patients, randomizing to masked drug infusions, and minimal occurrence of unblinding (n ¼ 6) or protocol violations (n ¼ 6).
Subjects
Subjects enrolled in this trial were either born at the participating tertiary NICUs (inborn) or were transported to one of these sites shortly after birth (outborn, from Level I or II NICUs). Ventilated preterm neonates of gestational age 23 to 32 weeks were randomized within 8 hours of intubation (if intubation occurred within 72 hours of birth) to a morphine treatment group or a placebo group. Thus, the postdelivery time spent at the referring facility was relatively short and uniform among all outborn babies.
Patients were excluded from participating in the study if any of the following were present: major congenital anomalies (requiring therapeutic interventions within 7 days of birth), severe intrapartum asphyxia (5-minute Apgar score r3 or cord blood pH r7.00), intrauterine growth restriction (birth weight <5th percentile for gestational age), current heroin or methadone addiction in the mother, or subjects' participation in research studies that would have the potential for drug interactions with morphine or long-term effects on the neurobehavioral development of preterm neonates.
Data Collection
Specially trained personnel collected data at each site, including maternal demographics, obstetric variables, severity of illness scores (Clinical Risk Index for Babies [CRIB]), 13 significant events during hospitalization and various outcome measures. Outcomes included severe IVH (Grades III and IV), 14 PVL (lesions adjacent to lateral ventricles), 15 CLD (defined as oxygen dependence at 36 weeks postconceptual age), and neonatal mortality (defined as death prior to hospital discharge or 28 days, whichever occurred first). The CRIB score included weighted values for birth weight, weeks of gestation (if r24 weeks), congenital malformations, metabolic acidosis, and minimum and maximum FIO2 in the first 12 hours of life.
Two cranial ultrasonograms were performed on each subject. For neonates born at <30 weeks gestation, one was peformed at 4 to 7 days of age and another at 28 to 35 days of age. Neonates born Z30 weeks gestation received a cranial ultrasonogram at 4 to 7 days of age and another at 14 to 28 days. Using 7 MHz sector transducers through the anterior fontanelle, [15] [16] [17] six saggital and six coronal ultrasound images were documented. All cranial sonograms from both US and European sites were interpreted centrally by two experienced pediatric radiologists at Arkansas Children's Hospital. Discrepancies between the two independent interpretations were evaluated and a consensus interpretation was used for analysis. Standardized assessment criteria were used for each echolucency site, other parenchymal lesions, ventricular size and contents, and IVH classification.
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Statistical Analysis
To determine if parental demographics, maternal clinical factors, and neonatal diagnoses were associated with inborn or outborn status, we performed t-tests for continuous variables and w 2 tests for categorical variables. Logistic regression analyses were used to examine associations between the birth center (inborn versus outborn) and defined outcomes, while adjusting for treatment group (morphine versus placebo) and gestational age groups (23 to 26, 27 to 29, and 30 to 32 completed weeks gestation). Following stepwise elimination of nonsignificant factors in these logistic models, point estimates and 95% confidence intervals of the odds ratio for each significant factor were presented. The fit of each logistic model was assessed using the Hosmer-Lemeshow goodness-of-fit test and the global test, that all regression parameters are zero, was tested using the À2 log likelihood statistic. All analyses were performed using the SAS program (version 8.1, Cary, NC, USA) and the critical p-value was set at 0.05.
RESULTS
A total of 746 inborn and 148 outborn neonates participated in the NEOPAIN trial (birth hospital data were unavailable for four subjects). Outborn neonates had similar gestational ages, severity of illness, and other characteristics as the inborn neonates, but had longer intervals to surfactant treatment, higher birth weights, and fewer neonates required resuscitation at birth ( Table 1) .
Mothers of inborn babies were slightly older than mothers of outborn babies (Table 2) , but no differences occurred in the maternal race ( p ¼ 0.1507), educational status (p ¼ 0.7423), gravida ( p ¼ 0.9408), or number of previous premature births ( p ¼ 0.3503). A greater incidence of obstetric complications (premature rupture of membranes, prolonged rupture of membranes, chorioamnionitis, and pre-eclampsia) occurred among the mothers of inborn versus outborn babies ( Table 2 ). The mothers of inborn babies were also more likely to receive antepartum therapies including magnesium, tocolytics, antibiotics, and complete courses of antenatal steroids. For example, nearly 90% of the mothers of inborn infants received antenatal steroids compared with 42% of the mothers of outborn infants ( Table 2) .
The rates of birth trauma, metabolic acidosis, hypothermia, early sepsis, anemia, thrombocytopenia, hyaline membrane disease, pulmonary hypertension, pulmonary hemorrhage, and seizures within the first 24 hours were not significantly different in the inborn and outborn neonates (Table 3) .
Outborn babies were more likely to have severe IVH after adjusting for treatment group and gestational age, but there was no significant difference in PVL, CLD, or death (Table 4) . If severity of illness (CRIB) was added to the regression model, the outborn babies continued to be more likely to have severe IVH (OR ¼ 2.2; 95% CI: 1.3 to 3.7) than the inborn preterm neonates.
If this model was adjusted for maternal treatment with antenatal steroids, the effect of outborn versus inborn birth was no longer significant (OR ¼ 1.3; 95% CI: 0.7 to 2.4). Other antenatal variables that were significantly different between the inborn and outborn babies on univariate analyse were found to be irrelevant when added to this logistic regression model (e.g. premature or prolonged rupture of membranes, chorioamnionitis, antenatal magnesium, or tocolytics). The risks of periventricular leukomalacia, chronic lung disease, or death were not significantly different for outborn versus inborn babies, after adjusting for treatment group and gestational age ( Table 4) . Outborn versus inborn birth had no significant effects on these outcomes even after adjusting for severity of illness (CRIB scores).
DISCUSSION
In the NEOPAIN trial, preterm neonates (23 to 32 weeks gestation) who were transported to Level III NICUs after birth were more likely to have severe IVH than inborn preterm neonates. However, after adjusting for maternal antenatal steroid use, the effect was no longer significant. The NEOPAIN trial was unique because time spent at the referral hospital NICU was limited, so the variability of neonatal care at the referring facility would have included the antenatal management, the delivery room resuscitation, and management during the first few hours of life. In this trial, neonates had to be enrolled within 8 hours of intubation, so the outborn infants had to arrive at the tertiary center no more than 7 hours after intubation to allow time for studying drug preparation. Thus, maternal perinatal care and the location of delivery, independent of center of care for the remainder of the premature neonate's hospitalization, are likely important factors contributing to the occurrence of severe IVH. There were several differences in maternal characteristics between the inborn and outborn populations, but the effects of other antenatal risk factors other than lack of antenatal steroids were not significant in our model. This analysis also suggests that the initial neonatal care and events during transport play a less significant role for these outcome differences.
In this study, location of birth alone did not appear to have a significant effect on survival for the transferred outborn babies versus the inborn babies. However, since babies who died before or during transport were excluded, outborn mortality may have been underestimated. The risk of periventricular leukomalacia or chronic lung disease was not significantly different between the inborn and outborn groups. Other studies have demonstrated significant differences in these outcomes. 4, 18, 19 Perhaps a large portion of the differences between inborn and outborn outcomes in previous studies can be attributed to variable neonatal care for those babies spending more time at the referring hospitals.
The average gestational age and severity of illness was not significantly different between outborn and inborn subjects. Significant differences in the antenatal risk factors, such as the greater occurrence of pre-eclampsia, premature and prolonged rupture of membranes, or chorioamnionitis among the mothers of inborn babies, reflect the high-risk obstetric services at tertiary referral centers. Based on these factors, the inborn babies would be expected to be sicker and perhaps have more complications than the outborn babies. Our data did not support this presumption.
Mothers of outborn babies were much less likely to receive antibiotics, tocolysis, and antenatal steroids (Table 3) . Antenatal steroid use, an important part of antenatal obstetric management, was more common in the inborn population. It has been associated with decreased IVH in a number of clinical trials and is the most likely reason for the decreased incidence of IVH in the inborn neonates from our study. 20 The use of antenatal corticosteroids also reduces the incidence and severity of hyaline membrane disease and necrotizing enterocolitis. 20 However, institutional variations in antenatal corticosteroid therapy for women expected to give preterm birth remains a significant problem, despite abundant evidence in the literature. 21 The study by Chien et al. 21 also found that outborn status was the most significant factor associated with lack of antenatal corticosteroid use (OR 3.64; 95% CI: 3.18 to 4.17).
One concern about the NEOPAIN study protocol is that the diagnosis of PVL may be missed by performing only two ultrasound scans. However, the timing of the second scan was such that >95% of patients with sonographically detectable PVL would be identified. While the more sophisticated technologies (CT, MRI, diffusionweighted CT, diffusion tensor imaging) can pick up more diffuse damage or smaller areas of PVL, the standard screening test in preterm neonates still remains the cranial ultrasonogram. Nevertheless, we postulate that similar proportions of babies with PVL would be missed in the inborn and outborn groups. Also, by enrolling only intubated neonates, this study focused on the effect of perinatal factors on the studied outcomes, so those babies who did not require intubation early would be excluded, possibly eliminating a significant portion of babies who were later diagnosed with PVL. One criticism of studies comparing transported neonates to inborn neonates is that there is selection bias, particularly that the less ill infants, who are not transported, as well as the extremely ill patients who do not survive to transport from referring hospitals, are excluded. In this study, we included only ill preterm babies requiring intubation who were likely to survive at least to enrollment, thus potentially decreasing this bias. The extremely ill subjects would be less likely to be included because they may not have survived to transport (outborn) or to enrollment (inborn). The less ill babies, those not requiring intubation, were excluded from both outborn and inborn populations. Intuitively, it would seem that babies with conditions requiring subspecialty evaluation (i.e. congenital heart disease or major anomalies requiring surgery) would do better when born at a tertiary center. However, our attention was focused on premature infants who did not have other risk factors such as birth asphyxia, severe growth restriction, or major congenital anomalies.
It has been suggested that the mothers of outborn subjects represent a different population than mothers of inborn subjects. A study by Warner et al. 10 found that of the 198 mothers of outborn babies evaluated, 52% (104) had cervical dilation <4 cm and 46% (48) delivered >12 hours after admission. With these data, we could reasonably expect that the vast majority of pregnant women at risk for preterm delivery should receive at least one dose of steroids. In our study, 89.9% of inborn mothers and 41.9% of outborn mothers received at least a partial course of steroids. Vaginal bleeding, which could lead to abruption and emergent delivery without the possibility of antenatal steroids, was not evaluated in our study.
One area for future study is the extreme variability in antenatal risk factors, such as the onset of obstetric complications and subsequent time to delivery. For example, a 27-week newborn whose mother has had recurrent preterm labor for weeks prior to delivery may have a lower risk for hyaline membrane disease than a 27-week newborn who was delivered precipitously after a relatively short labor. Another question for study is the role of tocolysis at the referring hospital compared to the tertiary centers. Although the tocolysis may not prevent preterm delivery, it may allow for a steroid course to be given. 22 Finally, it is not known how soon after a patient presents in preterm labor that she should receive steroids, antibiotics, and/or tocolysis. Since even a partial course of steroids was associated with improved outcome, the importance of early steroid administration cannot be underestimated. 20 If the time to steroid administration for at-risk mothers is significantly different between inborn and outborn neonates, this may represent an area where changes in protocols may make a significant difference in neonatal outcomes. This is particularly important because antenatal maternal transfer may not be possible for up to 50% of high-risk pregnancies. 20 Secondary analyses of the NEOPAIN database suggest that antenatal management of the mother at referring hospitals, including steroids, antibiotics if indicated, and perhaps tocolysis to allow time for steroid therapy, could have beneficial effects on the neonatal outcomes by a reduction of severe intraventricular hemorrhage. Further data are needed to evaluate antenatal variables and their effect on neonatal outcomes.
